One Pill, Three Meds: A New Strategy to Prevent Repeat Stroke

A single pill combining three blood pressure medications significantly reduced repeat strokes in patients with prior brain bleeds, according to a study published in The New England Journal of Medicine.

“Lowering blood pressure is the only proven method to prevent another stroke, yet achieving good blood pressure control is a real challenge,” said senior investigator Craig Anderson, Ph.D., a professor of neurology and epidemiology at the University of New South Wales Sydney and senior professorial fellow at The George Institute. “One big issue is that the number and doses of antihypertensive medications are not increased when needed, and doctors and patients struggle with complex pill regimens.”

What This Study Looked At

This study focused on people who had experienced an intracerebral hemorrhage, a serious type of stroke caused by bleeding in the brain. After this kind of stroke, controlling blood pressure is the most important way to reduce the risk of having another one. Investigators wanted to know whether taking a single pill that combines three low-dose blood pressure medications (telmisartan, amlodipine and indapamide) would be more effective than standard treatment alone.

How the Study Worked

More than 1,600 patients participated in this large, international trial. Everyone first took the triple-combination pill for two weeks. After that, participants were split into two groups: one group continued taking the triple pill, while the other switched to a placebo (a pill with no active medication). Researchers followed them for about 2.5 years to track blood pressure levels, repeat strokes, heart-related complications and safety.

Key Findings

The triple pill showed meaningful benefits compared to standard care alone:

• Lower risk of repeat stroke: 4.6% of patients on the triple pill had another stroke, compared to 7.4% on placebo
• Better blood pressure control: Average systolic blood pressure was significantly lower (127 mm Hg vs. 138 mm Hg)
• Fewer major cardiovascular events: Serious heart-related issues were less common in the triple-pill group

These results suggest that combining medications into one pill may improve outcomes by making treatment both more effective and easier to follow.

“Our study showed that GMRx2, a once-daily triple combination pill, cut the risk of another stroke by 39%,” said Anderson. “These findings could translate to important treatment benefits for the millions of people affected by intracerebral hemorrhage worldwide who face a high risk of having another one.”

Safety and Side Effects

Overall, serious side effects were slightly less common in the triple-pill group compared with those who received placebo (23.2% vs 26.0%, respectively). However, more patients stopped taking the triple pill early due to side effects. The most common reason was an increase in creatinine levels, which can indicate changes in kidney function. This highlights the importance of regular monitoring when using combination therapies.

What This Means for Patients

For patients recovering from a brain bleed stroke, this study suggests that a single pill combining multiple low-dose medications could offer a simpler and more effective way to control blood pressure and reduce the risk of another stroke. While not everyone will be a candidate for this approach, it may be worth discussing with your health care provider as part of a personalized treatment plan.

“These study results have the potential to mark a real shift in how we manage blood pressure following a stroke,” concluded Anderson. ”This single-pill triple combination helped patients reach target blood pressure levels.”